Guillem Pons

696 total citations
14 papers, 110 citations indexed

About

Guillem Pons is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, Guillem Pons has authored 14 papers receiving a total of 110 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 3 papers in Oncology and 3 papers in Pharmacology. Recurrent topics in Guillem Pons's work include Pharmacogenetics and Drug Metabolism (3 papers), Nausea and vomiting management (2 papers) and Wnt/β-catenin signaling in development and cancer (2 papers). Guillem Pons is often cited by papers focused on Pharmacogenetics and Drug Metabolism (3 papers), Nausea and vomiting management (2 papers) and Wnt/β-catenin signaling in development and cancer (2 papers). Guillem Pons collaborates with scholars based in Spain, France and Cameroon. Guillem Pons's co-authors include Jean‐Marc Tréluyer, Miguel F. Segura, Josep Roma, Soledad Gallego, G Olivé, J Lemerle, Lucas Moreno, Joan Sánchez-de-Toledo, Gabriel Gallo-Oller and Vincent Jullien and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Molecular Sciences and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Guillem Pons

14 papers receiving 106 citations

Peers

Guillem Pons
Nathan Pezant United States
B. J. Burke United Kingdom
Ali S. Alshanqeeti Saudi Arabia
Hang Yan China
Jaka Šikonja Slovenia
Woon‐Puay Koh Singapore
Nathan Pezant United States
Guillem Pons
Citations per year, relative to Guillem Pons Guillem Pons (= 1×) peers Nathan Pezant

Countries citing papers authored by Guillem Pons

Since Specialization
Citations

This map shows the geographic impact of Guillem Pons's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guillem Pons with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guillem Pons more than expected).

Fields of papers citing papers by Guillem Pons

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guillem Pons. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guillem Pons. The network helps show where Guillem Pons may publish in the future.

Co-authorship network of co-authors of Guillem Pons

This figure shows the co-authorship network connecting the top 25 collaborators of Guillem Pons. A scholar is included among the top collaborators of Guillem Pons based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guillem Pons. Guillem Pons is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Hladun, Raquel, Gabriela Guillén, Gabriel Gallo-Oller, et al.. (2023). Targeting the Hedgehog Pathway in Rhabdomyosarcoma. Cancers. 15(3). 727–727. 4 indexed citations
2.
Pons, Guillem, Gabriel Gallo-Oller, Miguel F. Segura, et al.. (2023). Analysis of Cancer Genomic Amplifications Identifies Druggable Collateral Dependencies within the Amplicon. Cancers. 15(6). 1636–1636. 1 indexed citations
3.
Gallo-Oller, Gabriel, Guillem Pons, Miguel F. Segura, et al.. (2021). Dickkopf Proteins and Their Role in Cancer: A Family of Wnt Antagonists with a Dual Role. Pharmaceuticals. 14(8). 810–810. 12 indexed citations
4.
Gallo-Oller, Gabriel, Guillem Pons, Miguel F. Segura, et al.. (2021). Dickkopf-1 Inhibition Reactivates Wnt/β-Catenin Signaling in Rhabdomyosarcoma, Induces Myogenic Markers In Vitro and Impairs Tumor Cell Survival In Vivo. International Journal of Molecular Sciences. 22(23). 12921–12921. 6 indexed citations
5.
Gallo-Oller, Gabriel, Guillem Pons, Lucas Moreno, et al.. (2020). miRNA-7 and miRNA-324-5p regulate alpha9-Integrin expression and exert anti-oncogenic effects in rhabdomyosarcoma. Cancer Letters. 477. 49–59. 22 indexed citations
6.
Pons, Guillem, E. Izquierdo, José Luı́s Abad, et al.. (2019). A Mechanism-Based Sphingosine-1-phosphate Lyase Inhibitor. The Journal of Organic Chemistry. 85(2). 419–429. 7 indexed citations
7.
Jullien, Vincent, Élie Azria, E. Pannier, et al.. (2009). Population analysis of the pregnancy-related modifications in lopinavir pharmacokinetics and their possible consequences for dose adjustment. Journal of Antimicrobial Chemotherapy. 63(6). 1223–1232. 18 indexed citations
8.
Jouan, Marc, Vincent Jullien, Tetanye Ekoe, et al.. (2005). Quinine Pharmacokinetics and Pharmacodynamics in Children with Malaria Caused by Plasmodium falciparum. Antimicrobial Agents and Chemotherapy. 49(9). 3658–3662. 15 indexed citations
9.
Alexandre, J M, V. Diéras, Sophie Grabar, et al.. (2005). Prospective study of predictive factors of docetaxel (DCX)-induced febrile neutropenia (FN): Relevance of in vivo cytochrome 3A (CYP3A) phenotyping. Journal of Clinical Oncology. 23(16_suppl). 2046–2046. 1 indexed citations
10.
Dupont, Christophe, et al.. (1998). Effet antisécrétoire du lansoprazole en pédiatrie : Étude pharmacocinétique et pH-métrique. Archives de Pédiatrie. 5(2). 234–235. 1 indexed citations
11.
Pariente‐Khayat, Ann, F Vauzelle-Kervroëdan, Enrique Rey, et al.. (1996). Pharmacokinetics of tiaprofenic acid in infants after a single oral dose.. PubMed. 34(8). 342–4. 2 indexed citations
12.
13.
Bertin, L., Enrique Rey, Guillem Pons, et al.. (1990). Pharmacokinetics of tiaprofenic acid in children after a single oral dose. European Journal of Pharmacology. 183(2). 629–630. 1 indexed citations
14.
Hartmann, Olivier, et al.. (1984). [Hypercalcemia associated with tumors in children. 20 cases].. PubMed. 41(8). 551–5. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026